Search filters

List of works by Catherine Stedman

A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial.

scientific article

Allopurinol might improve response to azathioprine and 6-mercaptopurine by correcting an unfavorable metabolite ratio

scientific article published in January 2011

Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients

scientific article published on 24 February 2011

Autoimmune Hepatitis in the East and the West.

scientific article

Autoimmune hepatitis: the role of environmental risk factors: a population-based study

scientific article published on 17 July 2013

Benefit of farnesoid X receptor inhibition in obstructive cholestasis

scholarly article

Current prospects for interferon-free treatment of hepatitis C in 2012.

scientific article published on January 2013

Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia

scientific article published in June 2002

Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.

scientific article published on 13 January 2012

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

scientific article published on 5 April 2017

Efficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection

scientific article published on 27 January 2017

Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial

scientific article published on 30 July 2016

Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice

scientific article published on 17 December 2003

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

scientific article published in June 2018

Has primary sclerosing cholangitis associated with Crohn's disease a better outcome?

scientific article published on 05 June 2012

Hepatobiliary ABC transporters: physiology, regulation and implications for disease.

scientific article published on June 2009

Herbal hepatotoxicity

scientific article

Impact of improved treatment on disease burden of chronic hepatitis C in New Zealand

scientific article published on 19 December 2014

Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis

scientific article published on 3 September 2011

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

scientific article published on 21 July 2015

Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study.

scientific article published on 15 December 2011

Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand

article

Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury

scientific article

Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial

scientific article published on October 14, 2010

Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs

scientific article published on 22 June 2019

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international

scientific article published on 11 July 2019

Population-based epidemiology study of autoimmune hepatitis: a disease of older women?

scientific article published in October 2010

Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study

scientific article

Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs

scientific article published on 12 March 2020

Reply: To PMID 21994151

scientific article published on 01 April 2013

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease

scientific article published on 01 October 2019

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection: A Randomized Trial

scientific article

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

scientific article

Sofosbuvir-velpatasvir with ribavirin for 24 weeks in hepatitis C virus patients previously treated with a direct-acting antiviral regimen

scientific article published on 12 May 2017

Transient elastography to assess liver stiffness in patients with inflammatory bowel disease

scientific article

Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis

scientific article published on 08 June 2020

Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction

scientific article published on November 8, 2012